Heritability of the weight loss response to gastric bypass surgery
- PMID: 21832118
- PMCID: PMC3200251
- DOI: 10.1210/jc.2011-1130
Heritability of the weight loss response to gastric bypass surgery
Abstract
Context: The use of Roux-en-Y gastric bypass (RYGB) surgery to treat severe obesity has grown dramatically. RYGB is highly effective, but the response in individual patients varies widely, and clinical predictors have been able to explain only a fraction of this variation.
Objective: Our objective was to determine whether there is a significant genetic contribution to weight loss after RYGB.
Methods: We genotyped 848 patients undergoing RYGB. Using identity-by-descent methods, we identified 13 pairs of first-degree relatives. We identified an additional 10 pairs of individuals who were living together but are not genetically related and randomly paired the remaining 794 individuals. We then compared weight loss within and across pairs.
Results: First-degree relative pairs had a similar response to surgery, with a 9% mean difference in excess weight loss between members of each pair. This similarity was not seen with cohabitating individuals (26% mean difference; P = 0.005 vs. first-degree pairs) or unrelated individuals (25% mean difference; P = 0.001). Cohabitating individuals had within-pair differences in weight loss no more similar than randomly paired individuals (P = 0.60). The pair relationship explained a significant portion of the variation in weight loss in first-degree relatives [intraclass correlation coefficient (ICC) = 70.4%; P = 0.02] but not in random subjects (ICC = 0.9%; P = 0.48) or genetically unrelated cohabitating individuals (ICC = 14.3%; P = 0.67).
Conclusions: Genetic factors strongly influence the effect of RYGB on body weight. Identification of the specific genes that mediate this effect will advance our understanding of the biological mechanisms of weight loss after RYGB and should help identify patients who will benefit the most from this intervention.
Figures
Comment in
-
Genetics: genotype determines weight loss after bariatric surgery.Nat Rev Endocrinol. 2011 Sep 20;7(11):630. doi: 10.1038/nrendo.2011.154. Nat Rev Endocrinol. 2011. PMID: 21931369 No abstract available.
Similar articles
-
The MC4R(I251L) allele is associated with better metabolic status and more weight loss after gastric bypass surgery.J Clin Endocrinol Metab. 2011 Dec;96(12):E2088-96. doi: 10.1210/jc.2011-1549. Epub 2011 Oct 5. J Clin Endocrinol Metab. 2011. PMID: 21976721 Free PMC article.
-
Randomized Controlled Trial of One Anastomosis Gastric Bypass Versus Roux-En-Y Gastric Bypass for Obesity: Comparison of the YOMEGA and Taiwan Studies.Obes Surg. 2019 Sep;29(9):3047-3053. doi: 10.1007/s11695-019-04065-2. Obes Surg. 2019. PMID: 31290104 Review.
-
Predictors of weight regain in patients who underwent Roux-en-Y gastric bypass surgery.Surg Obes Relat Dis. 2016 Nov;12(9):1640-1645. doi: 10.1016/j.soard.2016.08.028. Epub 2016 Aug 21. Surg Obes Relat Dis. 2016. PMID: 27989521
-
An Analysis of Mid-Term Complications, Weight Loss, and Type 2 Diabetes Resolution of Stomach Intestinal Pylorus-Sparing Surgery (SIPS) Versus Roux-En-Y Gastric Bypass (RYGB) with Three-Year Follow-Up.Obes Surg. 2018 Sep;28(9):2894-2902. doi: 10.1007/s11695-018-3309-6. Obes Surg. 2018. PMID: 29790130
-
Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.Dan Med J. 2015 Apr;62(4):B5057. Dan Med J. 2015. PMID: 25872541 Review.
Cited by
-
Advantages of percent weight loss as a method of reporting weight loss after Roux-en-Y gastric bypass.Obesity (Silver Spring). 2013 Aug;21(8):1519-25. doi: 10.1002/oby.20186. Epub 2013 May 13. Obesity (Silver Spring). 2013. PMID: 23670991 Free PMC article.
-
The importance of gene-environment interactions in human obesity.Clin Sci (Lond). 2016 Sep 1;130(18):1571-97. doi: 10.1042/CS20160221. Clin Sci (Lond). 2016. PMID: 27503943 Free PMC article. Review.
-
Parental Obesity Predisposition and Age of Onset Associate with Poor Response to Bariatric and Metabolic Surgery.Obes Surg. 2023 May;33(5):1519-1527. doi: 10.1007/s11695-023-06499-1. Epub 2023 Mar 1. Obes Surg. 2023. PMID: 36856989 Free PMC article.
-
Leveraging Genomic Associations in Precision Digital Care for Weight Loss: Cohort Study.J Med Internet Res. 2021 May 19;23(5):e25401. doi: 10.2196/25401. J Med Internet Res. 2021. PMID: 33849843 Free PMC article.
-
Precision medicine in adult and pediatric obesity: a clinical perspective.Ther Adv Endocrinol Metab. 2019 Jul 27;10:2042018819863022. doi: 10.1177/2042018819863022. eCollection 2019. Ther Adv Endocrinol Metab. 2019. PMID: 31384417 Free PMC article. Review.
References
-
- Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, Balise RR, Kraemer HC, King AC. 2007. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA 297:969–977 - PubMed
-
- Bray GA. 2008. Medications for weight reduction. Endocrinol Metab Clin North Am 37:923–942 - PubMed
-
- Kaplan LM. 2010. Pharmacologic therapies for obesity. Gastroenterol Clin North Am 39:69–79 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials